Lipid Modification for the Prevention of Cardiovascular Disease (NICE Guideline)

Summary of NICE guidance on lipid lowering with statins.

 Download a pdf version of the above chart.

Adapted from: NICE Clinical Guideline 181 (July 2014; updated July 2016) - Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

 


KEYWORDS: Acute coronary syndrome | Cardiovascular risk assessment | Lipid modification | Primary prevention of CVD | Secondary prevention of CVD | Statins


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases